These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3976477)

  • 41. Oxygen transport and cardiovascular function at extreme altitude: lessons from Operation Everest II.
    Sutton JR; Reeves JT; Groves BM; Wagner PD; Alexander JK; Hultgren HN; Cymerman A; Houston CS
    Int J Sports Med; 1992 Oct; 13 Suppl 1():S13-8. PubMed ID: 1483751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brief report: pressure support ventilation during an ascent and on the summit of Mt. Everest? A theoretical approach.
    Kleinsasser A; Loeckinger A
    High Alt Med Biol; 2002; 3(1):65-8. PubMed ID: 12006166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Echocardiographic Assessment of Right Ventricle Dimensions and Function After Exposure to Extreme Altitude: Is an Expedition to 8000 m Hazardous for Right Ventricular Function?
    Kurdziel M; Wasilewski J; Gierszewska K; Kazik A; Pytel G; Wacławski J; Krajewski A; Kurek A; Poloński L; Gąsior M
    High Alt Med Biol; 2017 Dec; 18(4):330-337. PubMed ID: 28816526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular arrhythmias. A guide to their localisation.
    Holt PM; Smallpeice C; Deverall PB; Yates AK; Curry PV
    Br Heart J; 1985 Apr; 53(4):417-30. PubMed ID: 3986056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Energy expenditure climbing Mt. Everest.
    Westerterp KR; Kayser B; Brouns F; Herry JP; Saris WH
    J Appl Physiol (1985); 1992 Nov; 73(5):1815-9. PubMed ID: 1474056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Speech production and cognitive deficits on Mt. Everest.
    Lieberman P; Protopapas A; Kanki BG
    Aviat Space Environ Med; 1995 Sep; 66(9):857-64. PubMed ID: 7487824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of bronchoalveolar lavage on the heart rhythm and conduction of the children with severe pneumonia].
    Gao M; Cui Z
    Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):252-6. PubMed ID: 24915909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxic ventilatory response in successful extreme altitude climbers.
    Bernardi L; Schneider A; Pomidori L; Paolucci E; Cogo A
    Eur Respir J; 2006 Jan; 27(1):165-71. PubMed ID: 16387950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Everest 1953, first ascent: a clinical record.
    Ward MP
    High Alt Med Biol; 2003; 4(1):27-37. PubMed ID: 12713709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of a hypobaric chamber for pre-acclimatization before climbing Mount Everest.
    Richalet JP; Bittel J; Herry JP; Savourey G; Le Trong JL; Auvert JF; Janin C
    Int J Sports Med; 1992 Oct; 13 Suppl 1():S216-20. PubMed ID: 1483780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ambulatory recording of physiological variables during an ascent of Mt Aconcagua.
    Wagner DR
    Wilderness Environ Med; 2011 Mar; 22(1):58-61. PubMed ID: 21377121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrocardiogram made on ascending the Mount Qomolangma from 50 m a. s. l.
    Shi ZY; Ning XH; Zhu SC; Zhao DM; Huang PG; Yang SY; Wang Y; Dong ZS
    Sci Sin; 1980 Oct; 23(10):1316-25. PubMed ID: 7433968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of hypoxic ventilatory response to exercise performance on Mount Everest.
    Schoene RB; Lahiri S; Hackett PH; Peters RM; Milledge JS; Pizzo CJ; Sarnquist FH; Boyer SJ; Graber DJ; Maret KH
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Jun; 56(6):1478-83. PubMed ID: 6735806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conduit vessel blood flow during the trek to Mount Everest base camp.
    Dumais V; Nault P; Tsertsvadze A; Forbes TL
    Wilderness Environ Med; 2011 Dec; 22(4):309-15. PubMed ID: 22000548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-altitude exposure of three weeks duration increases lung diffusing capacity in humans.
    Agostoni P; Swenson ER; Bussotti M; Revera M; Meriggi P; Faini A; Lombardi C; Bilo G; Giuliano A; Bonacina D; Modesti PA; Mancia G; Parati G;
    J Appl Physiol (1985); 2011 Jun; 110(6):1564-71. PubMed ID: 21436463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in plasma and red cell volumes during exposure to high altitude.
    Stokke KT; Rootwelt K; Wergeland R; Vale JR
    Scand J Clin Lab Invest Suppl; 1986; 184():113-7. PubMed ID: 3473608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenytoin and acute mountain sickness on Mount Everest.
    Wohns RN; Colpitts M; Clement T; Karuza A; Blackett WB; Foutch R; Larson E
    Am J Med; 1986 Jan; 80(1):32-6. PubMed ID: 3510539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human physiology at extreme altitudes on Mount Everest.
    West JB
    Science; 1984 Feb; 223(4638):784-8. PubMed ID: 6364351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetazolamide and exercise in sojourners to 6,300 meters--a preliminary study.
    Hackett PH; Schoene RB; Winslow RM; Peters RM; West JB
    Med Sci Sports Exerc; 1985 Oct; 17(5):593-7. PubMed ID: 4068966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The physiologic cipher at altitude: telemedicine and real-time monitoring of climbers on Mount Everest.
    Satava R; Angood PB; Harnett B; Macedonia C; Merrell R
    Telemed J E Health; 2000; 6(3):303-13. PubMed ID: 11110634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.